The latest content available from Springer
12 followers 8 artykułów/tydzień
Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis

Abstract Rationale : Valproic acid (VPA) is commonly used as a second-line mood stabilizer or augmentative agent in severe mental illnesses. However, population pharmacokinetic studies specific to psychiatric populations are limited, and clinical predictors for the precision application...

Sat May 11, 2024 19:14
Vaporized nicotine in utero results in reduced birthweight, increased locomotion, and decreased voluntary exercise, dependent on sex and diet in offspring

Abstract Rationale Clinical research has shown that prenatal exposure to nicotine may result in increased obesity risk later in life. Preclinical research has corroborated this finding, but few studies have investigated inhaled nicotine or the interaction with diet on obesity risk. Objective The aim of this study was to investigate...

Sat May 11, 2024 19:14
The effect of e-cigarettes on cognitive function: a scoping review

Abstract Aim Much research has been conducted on the acute effects of nicotine on human cognitive performance, demonstrating both enhancing and impairing cognitive effects. With the relatively recent introduction of electronic cigarettes (‘e-cigarettes’) as a smoking cessation device,...

Fri May 10, 2024 19:16
Adolescent alcohol binge drinking and withdrawal: behavioural, brain GFAP-positive astrocytes and acute methamphetamine effects in adult female rats

Abstract Rationale Alcopop beverages are generally the first alcoholic beverage that young females drink which contain high levels of sugar and alcohol. The over-consumption of these drinks may encourage alcohol co-administration with methamphetamine (METH) impacting on drinking behaviour...

Wed May 8, 2024 19:22
Pharmacologic profile of ITI-333: a novel molecule for treatment of substance use disorders

Abstract Rationale Medications are urgently needed to treat symptoms of drug withdrawal and mitigate dysphoria and psychiatric comorbidities that drive opioid abuse and relapse. ITI-333 is a novel molecule in development for treatment of substance use disorders, psychiatric comorbidities,...

Wed May 8, 2024 19:22

Zbuduj własny kanał informacyjny

Gotowy, by spróbować?
Rozpocznij 14-dniowy okres próbny, karta kredytowa nie jest wymagana.

Załóż konto